Updated Resources Available: FDA-Approved HIV Medicines

Medications.
Date
Aug. 03, 2022
Source
HIVinfo.NIH.gov

On March 30, the Food and Drug Administration (FDA) approved Triumeq PD (abacavir/dolutegravir/lamivudine) tablet for oral suspension, an antiretroviral drug that is used to treat HIV infection in children.

The updated fact sheet lists HIV medicines approved for the treatment of HIV infection in the United States. For more information, view the FDA-Approved HIV Medicines fact sheet.

Visit the Clinical Info Drug Database to learn more about approved HIV medicines, or download the Clinical Info mobile application to view the information on your Apple or Android devices.